| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/26/2013 | EP2606893A1 Sulphonylaminopyrrolidinone derivatives, their preparation and their therapeutic application |
| 06/26/2013 | EP2606033A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor |
| 06/26/2013 | EP2605771A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 06/26/2013 | CN103173459A Mouse-anti-human T cell antigen ZCH-2B8a monoclonal antibody variable region gene and use |
| 06/26/2013 | CN103173357A Ceriporia lacerata and application thereof |
| 06/26/2013 | CN103173322A Healthcare wine and its preparation method |
| 06/26/2013 | CN103172760A Method for preparing sulfated glycogen based on oysters or scallops |
| 06/26/2013 | CN103172619A 4-(substituted benzyl)-1(2H)-2,3-phthalazinone derivatives, and preparation methods, medicinal compositions and uses thereof |
| 06/26/2013 | CN103169957A Nano thrombin and preparation method thereof |
| 06/26/2013 | CN103169954A A method for the preparation of a high-temperature stable oxygen-carrier-containing pharmaceutical composition and the use thereof |
| 06/26/2013 | CN103169953A Collagen peptide-colla corii asini oral solution and preparation method thereof |
| 06/26/2013 | CN103169880A Traditional Chinese medicine composition for treating myelodysplastic syndrome and preparation method thereof |
| 06/26/2013 | CN103169853A Traditional Chinese medicine composition for treating kidney yin deficiency type aplastic anemia |
| 06/26/2013 | CN103169843A Compound medicine having radiation resisting and protecting effects |
| 06/26/2013 | CN103169834A Traditional Chinese medicine composition for treating refractory thrombocytopenia |
| 06/26/2013 | CN103169803A Traditional Chinese medicine composition with functions of tonifiying qi, nourishing yin and activating blood for treating myelodysplastic syndrome and preparation method thereof |
| 06/26/2013 | CN103169796A Medicine for treating agranulocytosis with fungal infection of blood disease patients |
| 06/26/2013 | CN103169783A Medicine for treating anovulatory dysfunctional uterine bleeding |
| 06/26/2013 | CN103169774A Medicament for treating leukemia combined pure red blood cell aplasia |
| 06/26/2013 | CN103169761A Effective part of traditional Chinese medicine compound Chinese angelica blood replenishing soup and synchronous preparation method and application thereof |
| 06/26/2013 | CN103169750A Ultrasonic extraction method for extracting flavone from dianthus superbus |
| 06/26/2013 | CN103169709A Application of thiadiazolo pyrimidone compounds in treatment of hypercalcemia and tumor bone metastases |
| 06/26/2013 | CN103169708A Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds |
| 06/26/2013 | CN103169682A Polysaccharide sulfate tablet and preparation method of polysaccharide sulfate tablet |
| 06/26/2013 | CN103169657A Self-emulsifier containing breviscapine phosphatidylcholine complex, and preparation method and use thereof |
| 06/26/2013 | CN103169634A Orange peel toothpaste |
| 06/26/2013 | CN102382204B Low-molecular-weight polysaccharide sulfate and preparation method and application thereof |
| 06/26/2013 | CN102274378B Brain-strengthening and thrombosis-resisting pills for treating cerebrovascular diseases and preparation method thereof |
| 06/26/2013 | CN102105142B Compositions for treating rosacea comprising chitosan and a dicarboxylic acid |
| 06/26/2013 | CN102060808B Cinepazide acid addition salt and preparation method thereof |
| 06/26/2013 | CN101953810B Breviscapine pill |
| 06/25/2013 | US8470854 Lactam-containing compounds and derivatives thereof as factor XA inhibitors |
| 06/25/2013 | US8470317 B7RP-1 antagonists |
| 06/25/2013 | CA2633074C Elongase genes and uses thereof |
| 06/25/2013 | CA2588963C 1-substituted-3-.beta.-d-glucopyranosylated nitrogenous hetero-cyclic compounds and medicines containing the same |
| 06/25/2013 | CA2536052C Novel crystalline compounds |
| 06/25/2013 | CA2506218C Use of plasma proteins concentrates containing vwf with a high proportion of high molecular weight multimers |
| 06/25/2013 | CA2405378C Stable taurolidine electrolyte solutions |
| 06/20/2013 | WO2013090357A1 Hemostatic agents and methods of use |
| 06/20/2013 | WO2013090321A1 Vasoconstrictor for use in the treatment of abnormal uterine bleeding |
| 06/20/2013 | WO2013089164A1 Thromboembolism preventive/therapeutic agent for thromboembolism patients having severe renal dysfunction |
| 06/20/2013 | WO2013088382A1 Therapy for subarachnoid hemorrhage and ischemia |
| 06/20/2013 | WO2013052736A9 Methods of treating or preventing blood loss during surgery using the serine protease inhibitor mdco-2010 |
| 06/20/2013 | WO2013045380A3 Pharmaceutically acceptable mglur5 positive allosteric modulators and their methods of identification |
| 06/20/2013 | US20130158480 Indwelling heat exchange catheter and method of using same |
| 06/20/2013 | US20130158069 Preventive and/or therapeutic agent for thromboembolism in thromboembolism patient with severe renal impairment |
| 06/20/2013 | US20130156695 Use of zcytor17 ligand antagonists for treating inflammatory diseases |
| 06/20/2013 | DE102006044448B4 Gelartiges Basenpräparat zur Supplementierung von Spurenelementen und Verfahren zu dessen Herstellung Gel-base preparation for supplementation of trace elements and process for its production |
| 06/19/2013 | EP2604697A1 Triprenyl phenol compounds, process for their production and use as thrombolysis enhancer |
| 06/19/2013 | CN103160485A Agkistrodon acutus hemocoagulase-C |
| 06/19/2013 | CN103160412A Health care medicinal liquor |
| 06/19/2013 | CN103160410A Blood circulation activating wine preparation method |
| 06/19/2013 | CN103159860A Recombinant tissue-type plasminogen activator, and preparation method and use thereof |
| 06/19/2013 | CN103159835A Lys and oligopeptide-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159827A Synthesis, anti-thrombotic activity, and application of (1R, 3S) -1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid |
| 06/19/2013 | CN103159826A Lys and Lys (Pro-Ala-Lys)-modified curcumin derivatives, and synthesis and medical application thereof |
| 06/19/2013 | CN103159760A Azaindole derivatives as cftr modulators |
| 06/19/2013 | CN103159758A (1S,3S)-1-p-nitrophenyl-1,2,3,4-tetrahydro-beta-carboline acyl amino acid, and synthesis, antithrombotic activity and application as antithrombotic agent thereof |
| 06/19/2013 | CN103157094A Pantoprazole sodium medicine composition for injection and preparation method thereof |
| 06/19/2013 | CN103157058A Traditional Chinese water-bindered pill preparation for treating osteomyelitis |
| 06/19/2013 | CN103157033A Medicament for treating iron deficiency anemia |
| 06/19/2013 | CN103157008A Medicine for treating aplastic anemia |
| 06/19/2013 | CN103156976A Traditional Chinese medicine dispersible tablet used for regulating menstruation and tonifying blood and preparation method thereof |
| 06/19/2013 | CN103156956A Blood replenishing oral liquid and preparation method thereof |
| 06/19/2013 | CN103156953A Blood circulation smoothing pill |
| 06/19/2013 | CN103156949A Medicament for treating aplastic anemia |
| 06/19/2013 | CN103156942A Compound essential oil capable of realizing dropsy elimination, detoxification and diuresis |
| 06/19/2013 | CN103156935A Method for extracting medicinal components from Xinjiang small roses |
| 06/19/2013 | CN103156910A Blood circulation smoothing bean |
| 06/19/2013 | CN103156836A Nafamostat mesilate composition and preparation method thereof |
| 06/19/2013 | CN103156810A Propofol microemulsion composition |
| 06/19/2013 | CN103156809A Furosemide injection and preparation method thereof |
| 06/19/2013 | CN102429886B Indapamide osmotic pump preparation and preparation method thereof |
| 06/19/2013 | CN102351948B Antithrombotic medicine RWR for specifically identifying platelet alpha<IIb>beta3 |
| 06/19/2013 | CN102300880B Carboxyethylated Cyclodextrin Polysulfates Useful As Medicaments |
| 06/19/2013 | CN102276585B Preparation method for and medicinal usage of 4-substituted-phenyl-aryl-carboxylate derivatives |
| 06/19/2013 | CN102260698B PTA-linker-thanatin fusion protein expressed in escherichia coli, and anticancer research thereof |
| 06/19/2013 | CN102250342B PEG/mPEG (Polyethylene Glycol) multi-carboxyl chemical modifying agent connected with citric acid, preparation method and application thereof in modification of toluylene compound |
| 06/19/2013 | CN102250127B Tetrahydro carboline derivative modified with two amino acids and preparation method and application thereof |
| 06/19/2013 | CN102241675B (1R,3S)-1-(4-hydroxyl-3-methoxycarboxyl)-1,2,3,4-tetrahydro-beta-carboline-3-formyl amino acid derivatives as well as preparation method and application thereof |
| 06/19/2013 | CN102240307B Preparation method of ginkgo leaf extract |
| 06/19/2013 | CN102199587B Functional mutant of human plasminogen, its preparation method and application |
| 06/19/2013 | CN102167695B Benzimidazole-carbonyl-pyridine-amino-ehtyl-propionate hemihyrate and its use |
| 06/19/2013 | CN101965200B Conjugated factor VIII molecules |
| 06/19/2013 | CN101914168B Medical applications and preparation methods of Pleurotus ferulae Lanzi polysaccharide and composites thereof |
| 06/19/2013 | CN101910189B Monosebacate of pyrazole derivative |
| 06/19/2013 | CN101906144B Conjugate formed by conjugating one Arg-Gly-Asp-Val chain and two fatty alcohol chains by Asp, synthesis thereof and medical application thereof |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | CA2567506C Cyclic amide derivatives, and their production and use as antithrombotic agents |
| 06/18/2013 | CA2534895C Hemostatic compositions containing sterile thrombin |
| 06/18/2013 | CA2429097C Composition of solutions for organ protection |
| 06/13/2013 | WO2013085017A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013085016A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | WO2013057592A3 Treatment of sickle cell disease |
| 06/13/2013 | WO2013051900A3 Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof |
| 06/13/2013 | US20130150296 Albumin fusion proteins |
| 06/13/2013 | CA2858164A1 Pyridone derivative and medicine containing same |
| 06/13/2013 | CA2762338A1 Therapy for subarachnoid hemorrhage and ischemia |